Recent Cancer Treatment Research for December 2024
Liver Cancer Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Laboratory Tests, Endoscopy, Imaging, Biopsy, and Others) and End User (Hospitals and Diagnostic Laboratories, Academic and Research Institutes, and CRO Labora
Topics: Cancer Treatment, COVID-19/Coronavirus, Hospitals & Clinics, Minimally Invasive Surgery, Endoscopy
Regions: Global
| 2022-2026 India Molecular Diagnostics Market Opportunities - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Infectious, Genetic, Cancer, Forensic and Paternity Tests - Latest Technologies and Instrumentation Pipeline,
Topics: Instrumentation & Equipment, Cancer Treatment, Molecular Diagnostics
Regions: India
| U.S. Clinical Nutrition Market Size By Product (Infant Nutrition {Milk Based, Soy Based, Organic Formulas}, Enteral Nutrition {Standard Composition, Disease Specific Composition}, Parenteral Nutrition {Amino Acids, Fats, Carbohydrates}), By Consumer (Pedi
Topics: Diabetes, Cancer Treatment, Clinical Nutrition, Drug Stores, CNS/Neurology, Gastrointestinal
Regions: United States
| Flow Cytometry Market by Product (Analyzer, Sorter, Reagents, Consumables, Software), Technology, Application (Research, Clinical - Cancer Diagnostics, Hematology), End User (Academia, Research Labs, Pharma, Biotech, Hospitals) - Global Forecast to 2026
Topics: Antibody Technologies, Stem Cell, Cancer Treatment, Hospitals & Clinics, Histology & Cytology, Oncology/Hematology
Regions: Global
| Global CAR-T Cell Therapy Market, By Product Type (Yescarta (Axicabtagene Ciloleucel), Kymriah (Tisagenlecleucel), Tecartus (Brexucabtagene Autoleucel), Breyanzi (Lisocabtagene Maraleucel), Abecma (Idecabtagene Vicleucel), Others), By Tumor Type (Hematolo
Topics: Stem Cell, Cancer Treatment, Hospitals & Clinics
Regions: Global
| 2021-2026 China Molecular Diagnostics Database: Market Shares and Forecasts for 100 Tests - Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing
Topics: Cancer Treatment, Molecular Diagnostics, Diseases & Conditions
Regions: China
| Hematological Malignancies Emerging Therapeutics Market - A Global and Regional Analysis: Focus on Therapeutic Type (Marketed), Potential Pipeline Products, Indication, and Region - Analysis and Forecast, 2021-2031
Topics: Antibody Technologies, Cell Culture, Cancer Treatment, Drug Discovery
Regions: Global
| Next-Generation Gynecological Cancer Diagnostics Market - A Global Market and Regional Analysis: Focus on Technology, Product Type, End User, and Country Analysis - Analysis and Forecast, 2020-2031
Topics: DNA Sequencing, Cancer Treatment, Hematology & Oncology, Oncology/Hematology, Obstetrics/Gynecology
Regions: Global
| Ocular Melanoma - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Head and Neck Squamous Cell Carcinoma - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Cancer Diagnostics Market Size By Application (Tumor Biomarkers Tests, Imaging {Ultrasound and Radiology, Mammography, MRI Scan, PET Scan, CT Scan, SPECT & Others}, Biopsy, Liquid Biopsy, Immunohistochemistry, In Situ Hybridization), By Cancer Type (Bladd
Topics: Biomarkers, Cancer Treatment, COVID-19/Coronavirus, Hospitals & Clinics, Computed Tomography (CT), Mammography, NMR & MRI, Ultrasonography, Oncology/Hematology, Men's Health
| Liquid Biopsy Global Market Report 2022
Including: 1) By Product: Assays Kits; Instruments; Services
2) By End User: Reference Laboratories; Hospitals and Physician Laboratories; Academic and Research Centers
3) By Clinical Application: Early Cancer Scr
Topics: Cancer Treatment, Hospitals & Clinics, Minimally Invasive Surgery, Orthopedics
Regions: Global
| 2022-2026 Costa Rica Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Vo
Topics: Cancer Treatment, Clinical Chemistry, Immunoassays
Regions: Costa Rica
| 2022-2026 Costa Rica Tumor Markers Testing Market High-Growth Opportunities for Cancer Diagnostic Tests and AnalyzersSupplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportuniti
Topics: Instrumentation & Equipment, Biomarkers, Cancer Treatment, Hematology & Oncology
Regions: Costa Rica
| Advanced Cervical Cancer - Pipeline Insight, 2021
Topics: Cancer Treatment, Drug Discovery, Women's Health, Oncology/Hematology, Obstetrics/Gynecology
| Advanced Gastric Carcinoma - Pipeline Insight, 2021
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Cancer Immunotherapy Market Forecasts to 2028 – Global Analysis By Application (Blood Cancers, Ovarian Cancer, Pancreatic Cancer, Liver Cancer), End User (Hospitals & Clinics, Ambulatory Surgical Centres) and By Geography
Topics: Drug Development, Cancer Treatment, Hospitals & Clinics, Prescription Drugs, Drug Discovery, Oncology/Hematology, Obstetrics/Gynecology
Regions: Global
| 2022-2026 Africa Clinical Chemistry and Immunodiagnostic Analyzers and Reagents in 6 Countries - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests, Latest Tech
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays
Regions: Africa
| 2022-2026 Chile Tumor Markers Testing Market High-Growth Opportunities for Cancer Diagnostic Tests and AnalyzersSupplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities fo
Topics: Instrumentation & Equipment, Biomarkers, Cancer Treatment, Hematology & Oncology
Regions: Chile
| 2022-2026 New Zealand Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, V
Topics: Cancer Treatment, Clinical Chemistry, Immunoassays
Regions: New Zealand
| 2022-2026 US Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays
Regions: United States
| 2022-2026 Venezuela Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Vol
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays
Regions: Venezuela
| 2022-2026 World Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests in 90 Countries High-Growth Opportunities for Suppliers, Competitive Shares and Growth Str
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays
Regions: Global
| Global Antibody Drug Conjugates (ADC); By Type (Cleavable Linker and Non-cleavable Linker), By Application (Blood Cancer (Leukemia, Multiple Myeloma, Lymphoma, Breast Cancer, Urothelial Cancer & Bladder Cancer and Others), By End Users (Research Institute
Topics: Antibody Technologies, Cancer Treatment, Hospitals & Clinics, Women's Health, Oncology/Hematology
Regions: Africa, Asia, Europe, North America, Oceania, South America, Global
| 2022-2026 Emerging Cancer Diagnostic Tests, Country Market Shares, Strategic Profiles of Leading Reagent and Instrument Suppliers
Topics: Cancer Treatment, Hematology & Oncology
| 2022 Cancer Diagnostic Instrumentation, and Strategic Profiles of Leading Suppliers
Topics: Instrumentation & Equipment, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
| 2022-2026 Asia-Pacific Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests in 18 Countries High-Growth Opportunities for Suppliers, Competitive Shares and Gro
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays
Regions: Asia, Oceania
| 2022-2026 Australia Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Vol
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays
Regions: Australia
| 2022-2026 Austria Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volum
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays
Regions: Austria
| 2022-2026 Belarus Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volum
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays
Regions: Belarus
| 2022-2026 Bolivia Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volum
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays
Regions: Bolivia
| 2022-2026 Brazil Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays
Regions: Brazil
| 2022-2026 Bulgaria Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volu
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays
Regions: Bulgaria
| 2022-2026 Russia Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays
Regions: Russia
| 2022-2026 Ukraine Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volum
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays
Regions: Ukraine
| 2022-2026 Ukraine Tumor Markers Testing Market High-Growth Opportunities for Cancer Diagnostic Tests and AnalyzersSupplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities
Topics: Instrumentation & Equipment, Biomarkers, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
Regions: Ukraine
| Laryngeal Cancer - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Primary Gastric Lymphoma - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Synchronous Endometrial and Ovarian Cancer (SEOC) - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Drug Discovery, Women's Health, Oncology/Hematology, Obstetrics/Gynecology
| Undifferentiated Pleomorphic Sarcoma - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Vulvar Squamous Cell Carcinoma - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology, Obstetrics/Gynecology
| Metastatic Cutaneous Squamous Cell Carcinoma - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Lung Adenocarcinoma - Epidemiology Forecast - 2032
Topics: Cancer Treatment, Drug Discovery
| South and Central America Monoclonal Antibodies Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Source (Human, Humanized, Chimeric, and Murine), Production Method (In-Vitro, and In-Vivo), Indication (Cancer, Autoimmune Diseases, Infecti
Topics: Antibody Technologies, Cancer Treatment, Autoimmune, COVID-19/Coronavirus, Hospitals & Clinics, Infectious Diseases
Regions: Central America
| 2022-2029 Global Cancer Biomarkers Professional Market Research Report, Analysis from Perspective of Segmentation (Competitor Landscape, Type, Application, and Geography)
Topics: Biomarkers, Cancer Treatment, Oncology/Hematology
Regions: Global
| Middle East and Africa Monoclonal Antibodies Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Source (Human, Humanized, Chimeric, and Murine), Production Method (In-Vitro, and In-Vivo), Indication (Cancer, Autoimmune Diseases, Infectious
Topics: Antibody Technologies, Cancer Treatment, Autoimmune, COVID-19/Coronavirus, Hospitals & Clinics, Infectious Diseases
Regions: Africa, Middle East
| Rat Model Market Size By Rat Type (Inbred, Outbred, Knockout, Hybrid), By Technology (CRISPR, Microinjection, Embryonic Stem Cell Injection, Nuclear Transfer), By Application (Research & Development, {Infectious Disease, Immunological Disease, Cancer, Car
Topics: Stem Cell, DNA Sequencing, Diabetes, Cancer Treatment, Veterinary Health
| Cervical Cancer Diagnostics Global Market Report 2022
Including: 1) By Diagnostic Test: Pap Smear Test; HPV Test; Colposcopy; Biopsy and Endocervical Curettage; Other Diagnostic Tests
2) By End User: Hospitals; Specialty Clinics; Cancer and Radiation The
Topics: Adults (18-55), Cancer Treatment, Hospitals & Clinics, Hematology & Oncology, Gynecological Devices, Women's Health, Obstetrics/Gynecology
Regions: Global
| 2022-2026 Albania Tumor Markers Testing Market High-Growth Opportunities for Cancer Diagnostic Tests and AnalyzersSupplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities
Topics: Instrumentation & Equipment, Biomarkers, Cancer Treatment, Hematology & Oncology
Regions: Albania
| 2022-2026 Finland Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volum
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays
Regions: Finland
|
Prev | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | Next
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 350 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.
|
